Pfizer is currently assessing the potential divestiture of its hospital drugs unit, a division mainly focused on antibiotics ...

Pfizer is exploring the sale of its hospital drugs unit, as the drugmaker, which has been under pressure from activist ...

Last month, the company sold a stake of approximately $3.26bn in Haleon, a UK-based consumer healthcare group. These strategic moves come as Pfizer, under the leadership of CEO Albert Bourla ...

Both GSK and Pfizer have been selling their holdings in Haleon at a fair clip. This month, Pfizer reduced its holding by 640m shares, selling them for ~$5.1 each for a total value of ~$2.43bn.

In October, Pfizer sold a stake worth about $3.26 billion in British consumer healthcare group Haleon. The moves come at a time when Pfizer, led by Chief Executive Albert Bourla, is facing ...